21st Nov 2018 11:38
LONDON (Alliance News) - Sensyne Health PLC on Wednesday said it signed a strategic advisory services agreement with consultancy and accountancy firm Ernst & Young.
Sensyne Health develops medical products using artificial intelligence.
Under the deal, Ernst & Young will provide "design and build" specialist resources comprising strategy, analytics, cyber, valuation, risk and governance capabilities.
Sensyne Health said this agreement with Ernst & Young will enable it to create global capacity and build on its business model.
"EY is recognised for their knowledge in the fast developing field of big data analytics and the associated valuation models needed to underpin equitable deal structures involving large datasets," said Sensyne Health Chief Executive Paul Drayson.
"We are delighted to be working together to create an ethical framework for the analysis of patient medical data for patient benefit," Drayson added.
Sensyne Health shares were down 7.0% on Wednesday at 165.00 pence.
Related Shares:
SENS.L